Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance

Biogen (BIIB) PT Lowered to $337 at RBC Capital

January 30, 2019 6:25 AM EST

RBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $337.00 (from $342.00) while maintaining a Sector Perform rating.

... More

Biogen (BIIB) PT Raised to $380 at Oppenheimer

January 29, 2019 5:29 PM EST

Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $380.00 (from $372.00) while maintaining a Outperform rating.

Olson noted an 'impressive' Q4 performance which featured a business update that perplexed investors with plans for an intriguing Alzheimer's prevention study.

... More